Latest filing published 27 Dec 2022 for ABIOMED INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jeannine M. Rivet: trading record in brief
Jeannine M. Rivet (board member) discloses dealings in Abiomed Inc to SEC (Form 4). Over a trading history stretching from 8 February 2016 to 10 August 2022, the count stands at 9 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 27 December 2022, reports a share grant in Abiomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeannine M. Rivet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,285 sharesCommon Stock, $0.01 par valueSEC:0001415889-22-013005:0
- 681 shares0Common Stock, $0.01 par valueSEC:0001415889-22-008525:0
- 625 shares0Common Stock, $.01 par valueSEC:0001179110-21-008176:0
- 3,513 sharesCommon Stock, $.01 par valueSEC:0001179110-16-018918:0
4 of 4 declarations
